0001209191-15-086111.txt : 20151218 0001209191-15-086111.hdr.sgml : 20151218 20151218162118 ACCESSION NUMBER: 0001209191-15-086111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151217 FILED AS OF DATE: 20151218 DATE AS OF CHANGE: 20151218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KARSEN PERRY A CENTRAL INDEX KEY: 0001260573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 151297062 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-17 0 0000816284 CELGENE CORP /DE/ CELG 0001260573 KARSEN PERRY A C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 0 1 0 0 see remarks Common Stock 2015-12-17 4 M 0 7500 0.00 A 70320 D Common Stock 2015-12-17 4 F 0 3888 112.17 D 66432 D Common Stock 1639 I 401(k) Plan Restricted Stock Unit 2015-12-17 4 M 0 7500 0.00 D Common Stock 7500 7500 D All of the restricted stock units granted to the reporting person on December 17, 2012 vested and settled for shares of the Company's common stock. The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 15, 2015). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. Chief Eecutive Officer of Celgene Cellular Therapeutics /s/ Robert J. Hugin ______________________________________________ Robert J. Hugin, Attorney-in-Fact 2015-12-18